跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NUCEIVA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NUCEIVA
Authorized
STANDARD
NUCEIVA
evolus incorporated
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
340b8f2a3fbefa6c
Company
evolus incorporated
Type
Standard
Approval Details
Approval Id
340b8f2a3fbefa6c
Drug Approval Canada Name
NUCEIVA
Product Name
NUCEIVA
Status
Marketed
Status Date
2019-10-16
Original Market Date
2019-10-16
Din
02480158
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intramuscular
Schedule
Schedule D , Prescription
Ahfs
12:20.20.24
Atc Original
M03AX01 BOTULINUM TOXIN
Atc Name
m 03 ax 01
Aig Number
0160590001
Company Name
evolus incorporated
Company Address
1200, 520 Newport Center Drive, Newport Beach, California, United States, 92660
Active Ingredients
PRABOTULINUMTOXINA
100 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
340b8f2a3fbefa6c
Type
Standard
Back to Health Canada Approvals